Abstract
Certain neurotransmitters are synthesized from precursor amino acids (e. g. catecholamines from tyrosine; serotonin [5-hydroxytryptamine or 5HT] from tryptophan) which must be obtained from the circulation. The concentrations of tyrosine and tryptophan, as well as of the other large neutral amino acids (LNAA) in plasma, are subject to wide variations (1, 2), changing not only when people or animals receive various drugs (3, 4) or the amino acids themselves (5, 6), but also in disease states affecting amino acid metabolism (7, 8), and, of major physiological relevance, in association with eating (1, 2) or with strenuous exercise (9, 10, 11). As will be described below, these variations often cause parallel changes in the levels of these amino acids within the monoaminergic neurons, and thereby may influence both neurotransmitter synthesis and even central neurotransmission (12).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
FERNSTROM, J. D., WURTMAN, R. J., HAMMARSTROM-WIKLUND, B., RAND, W. M., MUNRO, H. N., and DAVIDSON, C. S. (1979). Diurnal variations in the plasma concentrations of tryptophan, tyrosine and other neutral amino acids: Effect of dietary protein intake. Am. J. Clin. Nutr. 32: 1912 – 1922.
MAHER, T. J., GLAESER, B. S., and WURTMAN, R. J. (1984). Diurnal variations in the plasma concentrations of basic and neutral amino acids in red cell concentrations of aspartate and glutamate: Effects of dietary protein intake. Am. J. Clin. Nutr. 39: 722 – 729.
BADWAY, A. A. B., and EVANS, M. (1981). Inhibition of rat liver pyrrolase activity and elevation of brain tryptophan by administration of antidepressants. Biochem. Pharmacol. 30: 1211–1216.
VALZELLI, L., BERNASCONI, S., COEN, E., and PETKOV, V. V. (1980). Effect of different psychoactive drugs on serum and brain tryptophan levels. Neuropsychobiol. 6: 224 – 229.
GLAESER, B., MELAMED, E., GROWDON, J. H., and WURTMAN, R. J. (1979). Elevation of plasma tyrosine after a single oral dose of L-tyrosine. Life Sci. 25: 265–272.
FERNSTROM, J. D., and WURTMAN, R. J. (1971). Brain serotonin content: Physiological dependence on plasma tryptophan levels. Science 173: 149–152.
CURZON, G. (1980). Transmitter metabolism and behavioral abnormalities in liver failure. In: The Biochemistry of Psychiatric Disturbances. ( Curzon, G. ed.), pp. 89–111. Wiley, Chichester.
CURZON, G., KANTAMANENI, B. D., CALLIGHAN, N., and SULLIVAN, P. A. (1982). Brain transmitter precursors and metabolites in diabetic ketoacidosis. J. Neurol. Neurosurg. Psychiat. 45: 489–493.
ACWORTH, I. N., NICHOLASS, J., MORGAN, B., and NEWSHOLME, E. A. (1986). Effect of sustained exercise on concentrations of plasma aromatic and branched-chain amino acids and brain amines. Biochem. Biophys. Res. Commun. 137: 149–163.
ACWORTH, I. N., DURING, M. J., WATKINS, C. J., KREMPF, M. ELSENBERG, M., and WURTMAN, R. J. (1987). The effects of marathon running on plasma free and total large neutral amino acids and free fatty acids. In preparation.
DECOMBAZ, J., REINHARDT, P., ANANTHARAMAN, K., von GLUTZ, G., and POORTMANS, J. R. (1979). Biochemical changes in a 100 km run: Free amino acids, urea, and creatine. Eur. J. Appl. PhysioL 41: 61–72.
WURTMAN, R. J., HEFTI, F., and MELAMED, E. (1980). Precursor control of neurotransmitter synthesis. Pharmacol. Rev. 32: 315–335.
FERNSTROM, J. D., and WURTMAN, R. J. (1972). Brain serotonin content: Physiological regulation by plasma neutral amino acids. Science 178: 414–416.
FERNSTROM, J. D., and FALLER, D. V. (1978). Neutral amino acids in the brain: Changes in response to food ingestion. J. Neurochem. 30: 1531–1538.
YOKOGOSHI, H., and WURTMAN, R. J. (1986). Meal compositions and plasma amino acid ratios: Effect of various proteins and carbohydrates, and of various protein concentrations. Metabolism 35: 837–842.
PARDRIDGE, W. M. (1979). Regulation of amino acid availability to the brain: Selective control mechanisms for glutamate. In: Glutamic Acid: Advances in Biochemistry and Physiology ( Filer, L. J., Kare, M. R., Garattini, S., and Wurtman, R. J., eds.), pp. 125–137. Raven Press, New York.
BARRA, H. S., UNATES, L. E., SAAVERDRA, M. S., and CAPPUTO, R. (1972). Capacities of binding amino acids by t-RNAs from rat brain and their changes during development. J. Neurochem. 19: 2287–2297.
STANBURY, J. B., WYNGAARDAN, J. B., and FREDRICKSON, D. S. (1966). The Metabolic Basis for Inherited Disease. McGraw-Hill Book Co., New York.
KAYE, W. H., GWIRTSMAN, H. E., BREWERTON, T. D., GEORGE, T. D., and WURTMAN, R. J. (1987). Bingeing behavior and plasma amino acids: A possible involvement of brain serotonin in bulimia nervosa. Psychiatr. Res. (submitted).
FERNSTROM, J. D., and WURTMAN, R. J. (1971). Brain serotonin content: Increase following ingestion of carbohydrate diet. Science 174: 1023–1025.
BRADFORD, H. F. (1986). Chemical Neurobiology. W. H. Freeman and Co., New York.
FERNSTROM, J. D., and WURTMAN, J. R. (1972). Elevation of plasma tryptophan by insulin in the rat. Metabolism 21: 337–342.
McMENAMY, R. H., and ONCLEY, J. L. (1958). The specific binding of L-tryptophan to serum albumin. J. Biol. Chem. 233: 1436–1440.
MADRAS, B. K., COHEN, E. L., MESSING, R., MUNRO, H. N., and WURTMAN, R. J. (1974). Relevance of serum-free tryptophan to tissue tryptophan concentrations. Metabolism 23: 1107–1116.
KNOTT, P. J., and CURZON, G. (1972). Free tryptophan in plasma and brain tryptophan metabolism. Nature 239: 452–453.
YUWILER, A., OLDENDORF, W. H., GELLER, E., and BRAUN, L. (1977). The effect of albumin binding and amino acid competition on tryptophan uptake into brain. J. Neurochem. 28: 1015–1023.
PARDRIDGE, W. M., and OLDENDORF, W. H. (1975). Kinetic analysis of blood-brain barrier transport of amino acids. Biochem. Biophys. Acta. 401: 128–136.
PARDRIDGE, W. M. (1986). Potential effects of the dipeptide sweetener aspartame on the brain. In: Nutrition and the Brain ( Wurtman, R. J., and Wurtman, J. J., eds.) 7, pp. 199–241. Raven Press, New York.
LEIBERMAN, H., CABALLERO, B., and FINER, N. (1986). The composition of lunch determines afternoon plasma tryptophan ratios in humans. J. Neural. Transm. 65: 211–217.
ASHLEY, D. V. M., FLEURY, M. O., GOLAY, A., MAEDER, E., and LEATHWOOD, P. D. (1985). Evidence for deminished brain 5HT biosynthesis in obese diabetic and non-diabetic humans. Am. J. Clin. Nutr. 42: 1240–1245.
CABALLERO, B., FINER, N., and WURTMAN, R. J. (1987). Plasma amino acid levels in obesity: Effects of insulin resistance. In: Amino Acids in Health and Disease: New Prospectives. ( Kaufman, S., ed.), pp. 369–382. Alan R. Liss Inc., New York.
HERAIEF, E., BUCKHARDT, P., MAURON, C., WURTMAN, J. J., and WURTMAN, R. J. (1983). The treatment of obesity by carbohydrate deprivation suppresses plasma tryptophan and its ratio to other neutral amino acids. J. Neural. Transm. 57: 187–195.
FERNSTROM, J. D., WURTMAN, R. J., HAMMARSTROM-WIKLUND, B., RAND, W. M., MUNRO, H. N., and DAVIDSON, C. S. (1979). Diurnal variations in plasma amino acid concentrations in patients with cirrhosis: Effect of dietary protein. Am. J. Clin. Nutr. 32: 1923–1933.
FERNSTROM, J. D., ARNOLD, M. A., WURTMAN, R. J., HAMMARSTROM-WIKLUND, B., MUNRO, H. N., and DAVIDSON, C. S. (1978). Diurnal variations in plasma insulin concentrations in normal and cirrhotic subjects: Effect of dietary protein. J. Neural. Transm. 14: 133–142.
BLOXAM, D. L., and CURZON, G. (1978). A study of proposed determinants of brain tryptophan concentration in rats after portocaval anastomosis or sham operation. J. Neurochem. 31: 1255 1263.
ASHCROFT, G. W., ECCLESTON, D., and CRAWFORD, T. B. B. (1965). 5-hydroxyindole metabolism in rat brain: A study of intermediate metabolism using the technique of tryptophan loading. J. Neurochem. 12: 483–492.
YOUNG, S. (1985). The clinical psychopharmacology of tryptophan. In: Nutrition and the Brain. ( Wurtman, R. J., and Wurtman, J. J., eds.) 7, pp. 49–88. Raven Press, New York.
COLMENARES, J. L., WURTMAN, R. J., and FERNSTROM, J. D. (1975). Effect of ingesting a carbohydrate-fat meal on the levels and synthesis of 5-hydroxyindoles in various regions of the rat central nervous system. J. Neurochem. 25: 825–829.
MORET, C. (1985). Pharmacology of the serotonin autoreceptor. In: Neuropharmacology of Serotonin. ( Green, A. R., ed.), pp. 21–49. Oxford University Press, New York.
COOPER, J. R., BLOOM, F. E., and ROTH, R. H. (1982). The Biochemical Basis of Neuropharmacology. Oxford University Press, New York.
GALLAGER, D. W., and AGHAJANIAN, G. K. (1976). Inhibition of firing of raphe neurons by tryptophan and 5-hydroxy-tryptophan: Blockage by inhibiting serotonin synthesis with R04-4602. Neuropharmacology 14: 149–158.
BRAMWELL, G. (1974). Factors affecting the activity of 5HT containing neurons. Brain Res. 79: 515–519.
DE SIMONI, M. G., SOKOLA, A., FODRITTO, F., TOSO, G. D., and ALGERI, S. (1987). Functional meaning of tryptophan-induced increase of 5-HT metabolism as clarified by in vivo voltammetry. Brain Res. 411: 89–94.
SCHAECHTER, J., and WURTMAN, R. J. (1987). Effect of tryptophan availability on release of endogenous serotonin from rat hypothalamic slices. Society for Neuroscience Abstracts Volume 13, New Orleans.
SMITH, B., and PROCKUP, D. J. (1962). Central-nervous-system effects of ingestion of L-tryptophan by normal subjects. N. Engl. J. Med. 267: 1338–1341.
MOLLER, S. E., KIRK, L., and HONORE, P. (1980). Relationship between plasma ratio of tryptophan to competing amino acids and the response to L-tryptophan treatment in endogenously depressed patients. J. Affective Disord. 2: 47–49.
WILCOCK, G. K., STEVENS, J., and PERKINS, A. (1987). Trazadone/tryptophan for aggressive behavior. Lancet 1: 929–930.
MacINDOE, J. H., and TURKINGTON, R. W. (1973). Stimulation of human prolactin secretion by intravenous infusion of L-tryptophan. J. Clin. Investig. 52: 1972–1978.
SPRING, B. (1985). Effects of foods and nutrients on the behavior of normal individuals. In: Nutrition and the Brain. ( Wurtman, R. J., and Wurtman, J. J., eds.) 7, pp. 1–47. Raven Press, New York.
SPRING, B., MALLER, O., WURTMAN, J. J., DIGMAN, L., and COZOLINO, L. (1983). Effects of protein and carbohydrate meals on mood and performance. J. Psychiatr. Res. 17: 155–167.
PRINZ, R. J., ROBERTS, W. A., and HARTMAN, E. (1980). Dietary correlates of hyperactive behavior in children. J. Consult. Clin. Psychol. 48: 760–769.
ROSENTHAL, N. E., and HEFFERMAN, M.M. (1985). Bulimia, carbohydrate craving, and depression: A central connection. In: Nutrition and the Brain. ( Wurtman, R. J., and Wurtman J. J., eds.) 7, pp. 139–166. Raven Press, New York.
WURTMAN, J. J., WURTMAN, R. J., GROWDON, J. H., LIPSCOMB, H. P., and ZEISEL, S. A. (1981). Carbohydrate craving in obese people: Supression by treatments affecting serotoninergic transmission. Int. J. Eating Disord. 1: 2–15.
REID, R. (1985). Premenstrual syndrome. Current Problems in Obstetrics 8: 1–57.
VAN PRAAG, H. M., and LEMUS, C. (1985). Monoamine precursors in the treatment of psychiatric disorders. In: Nutrition and the Brain. ( Wurtman, R. J., and Wurtman, J. J., eds.) 7, pp. 89–138. Raven Press, New York.
ANDERSON, G. H. (1977). Regulation of protein intake by plasma amino acids. In: Advances in Nutritional Research. ( Draper, H. H., ed.) 1, pp. 145–166. Plenum Press, New York.
WURTMAN, J. J., and WURTMAN, R. J. (1979). Drugs that enhance central serotoninergic transmission diminish elective carbohydrate consumption by rats. Life Sci. 24: 895–904.
YOKOGOSHI, H., THEALL, C. L., and WURTMAN, R. J. (1986). Selection of dietary protein and carbohydrate by rats: Changes with maturation. Physiol. and Behavior 36: 972–982.
WURTMAN, J. J., and BAUM, M. (1980). Estrogen reduces total food and carbohydrate intake in female rats. Physiol. and Behavior 24: 823–827.
WURTMAN, J. J., MOSES, P. L., and WURTMAN, R. J. (1983). Prior carbohydrate consumption affects the amount of carbohydrate that rats choose to eat. J. Nutr. 113: 70–78.
KIM, S.-H., and WURTMAN, R. J. (1987). Selective effects of CGS 10686B, DL-fenfluramine or fluoxetine on nutrient selection. Physiol. and Behavior (Submitted).
WURTMAN, J. J., WURTMAN, R. J., MARK, S., TSAY, R., GILBERT, W., and GROWDON, J. H. (1985). D-fenfluramine selectively suppresses carbohydrate snacking by obese subjects. Int. J. Eating Disorders. 4: 89–99.
CHAOULOFF, F., KENNET, G. A., SERRURRIER, B., MERINO, D., and CURZON, G. (1986). Amino acid analysis demonstrates that increased plasma free tryptophan causes the increase in brain tryptophan during exercise in the rat. J. Neurochem. 46: 1647–1650.
ACWORTH, I. N., MORGAN, B., and NEWSHOLME, E. A. (1987). Dopamine turnover is increased in the brains of untrained and trained rats after endurance exercise. In preparation.
CHAOULOFF, F., LAUDE, D., GUEZENNEC, Y., and ELGHOZI, J. L. (1986). Motor activity increases tryptophan, 5HIAA and HVA in ventricular CSF of the conscious rat. J. Neurochem. 46: 1313-1316.
BLISS, E. L., and AILION, J. (1971). Relationship between stress and activity to brain dopamine and homovanillic acid. Life Sci. 10: 1161–1169.
RANSFORD, C. P. (1982). A role for amines in the antidepressant effect of exercise: A review. Med. Sci. Sports Exer. 14: 1–10.
BROWN, B. S., RAMIREZ, D. E., and TAUB, J. M. (1978). The prescription of exercise for depression. Phys. Sportsmed. 6: 34–45.
COHEN, E., and WURTMAN, R. J. (1976). Brain acetylcholine synthesis: Control by dietary choline. Science 191: 561–562.
SCHWARZ, J. C., LAMPART, C., and ROSE, C. (1972). Histamine formation in rat brain in vivo: Effects of histidine loads. J. Neurochem. 19: 801–810.
MAHER, T. J., and WURTMAN, R. J. (1980). L-threonine administration increases glycine concentrations in the rat central nervous system. Life Sci. 26: 1283–1286.
NADER, T. M. A., GROWDON, J. H., MAHER, T. J., and WURTMAN R. J. (1986). Lthreonine administration increases CSF glycine levels and suppresses spasticity. American Academy of Neurology Meeting. New York.
WOOD, J. L., and ALLISON, R. G. (1981). Effects of consumption of choline and lecithin on neurological and cardiovascular systems. In: FASEB: Technical Report, pp. 1–105. SRO Press, Washington.
SVED, A. F. (1983). Precursor control of the function of monoaminergic neurons. In: Nutrition and the Brain ( Wurtman, R. J., and Wurtman, J. J., eds.) 6, pp. 223–275. Raven Press, New York.
WURTMAN, R. J., LARIN, F., MOSTAFAPOUR, S., and FERNSTROM, J. D. (1974). Brain catechol synthesis: Control of brain tyrosine concentration. Science 185: 183-184.
SCALLY, M. C., ULUS, I., and WURTMAN, R. J. (1977). Brain tyrosine levels control striatal dopamine synthesis in haloperidol-treated rats. J. Neural. Transm. 41: 1–6.
GIBSON, C. J., and WURTMAN, R. J. (1978). Physiological control of brain norepinephrine synthesis by brain tyrosine concentration. Life Sci. 22: 1399–1406.
MELAMED, E., HEFTI, F., and WURTMAN, R. J. (1980). Tyrosine administration increases striatal dopamine release in rats with partial nigrostriatal lesions. Proc. Natl. Acad. Sci. USA 464: 4305-4309.
SVED, A. F., FERNSTROM, J. D., and WURTMAN, R. J. (1979). Tyrosine administration decreases serum prolactin levels in chronically reserpinized rats. Life Sci. 25: 1293–1300.
EL MESTIKAWAY, S., GLOWINSKI, J., and HAMON, M. (1983). Tyrosine hydroxylase activation in depolarized dopaminergic terminals: Involvement of calcium. Nature 302: 830–832.
LOVENBERG, W., AMES, M. M., and LERNER, P. (1978). Mechanisms of short-term regulation of tyrosine hydroxylase. In: Psychopharmacology: A Generation of Progress ( Lipton, M. A., DiMascio, A., and Killam, K. F., eds.), pp. 247–259. Raven Press, New York.
MILNER, J. D., and WURTMAN, R. J. (1986). Catecholamine synthesis: Physiological coupling to precursor supply. Biochem. Pharmacol. 35: 875–881.
IRIE, K., and WURTMAN, R. J. (1987). Release of norepinephrine from rat hypothalamic slices: Effects of desipramine and tyrosine. Brain Res. In press.
CONLAY, L. A., MAHER, T. J., and WURTMAN, R. J. (1981). Tyrosine increases blood pressure in hemorrhagic shock. Science 212: 559–560.
SVED, A. F., FERNSTROM, J. D., and WURTMAN, R. J. (1979). Tyrosine administration reduces blood pressure and enhances brain norepinephrine release in spontaneously-hypertensive rats. Proc. Natl. Acad. Sci. USA 76: 3511–3514.
GROWDON, J. H. (1979). Neurotransmitter precursors in the diet: Their use in the treatment of disease. In: Nutrition and the Brain ( Wurtman, R. J., and Wurtman, J. J., eds.) 3, pp. 117–181. Raven Press, New York.
LEHNERT, H., REINSTEIN, D. K., STROWBRIDGE, B. W., and WURTMAN, R. J. (1984). Neuro-chemical and behavioral consequences of acute, uncontrollable stress: Effects of dietary tyrosine. Brain Res. 303: 215–223.
REINSTEIN, D. K., LEHNERT, H., and WURTMAN, R. J. (1985). Dietary tyrosine suppresses the rise in plasma corticosterone following acute stress in rats. Life Sci. 37: 2157–2163.
BANDERET, L. E., LIEBERMAN, H. R., FRANCESCONI, R. P., GOLDMAN, R. F., SCHNAKEN-BERG, D. D., RAUCH, T. M., ROCK, P. B., and MEADORS, G. F. (1987). Development of a paradigm to assess nutritive and biochemical substances in humans: A preliminary report on the effects of tyrosine upon altitude-and cold-induced stress responses. In: Biochemical Enhancement of Performance. The “AGARD” Conference Proceedings. No. 415. Specialized Printing Services Lt., Loughton, Essex.
MILNER, J. D., IRIE, K., and WURTMAN, R. J. (1986). Phenylalanine inhibition and enhancement of endogenous dopamine release from rat striatal slices. J. Neurochem. 47: 1444–1448.
DURING, M. J., ACWORTH, I. N., and WURTMAN, R. J. (1987). An in vivo study of dopamine release in striatum: The effects of phenylalanine. In press. In: Dietary Phenylalanine and brain function ( Wurtman, R. J., and Ritter-Walker, E., eds.). Birkhauser, Boston.
IKEDA, M., LEVITT, M., and UDENFRIEND, S. (1967). Phenylalanine as substrate and inhibitor of tyrosine hydroxylase. Arch. Biochem. Biophys. 120: 420-427.
DURING, M. J., ACWORTH, I. N., and WURTMAN, R. J. (1987). Precursor influence on in vivo dopamine release: Regional effects of tyrosine. Brain Res. Submitted.
ANDEN, N. E., GRABOWSKA-ANDEN, M., LINDGREN, S., and THORNSTROM, U. (1983). Synthesis rate of dopamine: Difference between corpus striatum and limbic system as a possible explanation of variations in reactions to drugs. Nauyn-Schmiedeberg’s Arch. Pharmacol. 323: 193198.
BANNON, M. J., and ROTH, R. H. (1983). Pharmacology of mesocortical dopamine neurons. Pharmacol. Rev. 35: 53-68.
YOKOGOSHI, H., ROBERTS, C. H., CABALLERO, B., and WURTMAN, R. J. (1984). Effects of aspartame and glucose administration on brain and plasma levels of large neutral amino acids and brain 5-hydroxyindoles. Am. J. Clin. Nutr. 40: 1–7.
MAHER, T. J., and PINTO, J. M. B. (1987). Aspartame, phenylalanine, and seizures in experimental animals. In press. In: Dietary Phenylalanine and Brain Function ( Wurtman, R. J., and Ritter-Walker, E., eds.). Birkhauser, Boston.
JOHNS, D. R. (1987). Aspartame and headache. In press. In: Dietary Phenylalanine and Brain Function (Wurtman, R. J., and Ritter-Walker, E., eds.). Birkhauser, Boston.
NUTT, J. G., WOODWARD, W. R., HAMMARSTAD, J. P., and CARTER, J. H. (1984). The “on-off” phenomenon in Parkinson’s disease: Relation to levodopa absorption and transport. N. Eng. J. Med. 310: 483–488.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Acworth, I.N., During, M.J., Wurtman, R.J. (1988). Pprocesses That Couple Amino Acid Availability to Neurotransmitter Synthesis and Release. In: Huether, G. (eds) Amino Acid Availability and Brain Function in Health and Disease. NATO ASI Series, vol 20. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73175-4_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-73175-4_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-73177-8
Online ISBN: 978-3-642-73175-4
eBook Packages: Springer Book Archive